BioCryst Pharma (BCRX) PT Raised to $25 at JMP Securities

January 11, 2022 3:12 AM EST Send to a Friend
JMP Securities analyst Jonathan Wolleben ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login